- €72.93m
- €70.77m
- €10.97m
Brief: Nexstim Gets Order for NBS 6 System From European Hospital
Brief: US University Customer Purchases Nexstim NBS 6 For Research Purposes
Brief: Nexstim Gets NBS 6 System Order For European Hospital
Brief: Nexstim Gets Order From New U.S. Customer
Brief: Nexstim H1 EBITDA Up At EUR 0.3 Mln
Brief: Nexstim Gets Order For Additional NBS 6 Therapy System
Brief: Delve Psychiatry Upgrades To Nexstim's NBS 6 Platform
Brief: Nexstim Receives Order For 10 NBS 6 Systems
Brief: Nexstim Gets Expanded Health Canada Approval
Brief: Nexstim Secures First NBS 6 Sale Following Malaysian Market Authorization
Brief: Nexstim Gets Malaysian Authorization For NBS System 6
Brief: Nexstim Receives NBS 6 Therapy System Order From New US Customer
Brief: Nexstim Wins Authorization In Australia
Brief: Nexstim Receives Order From Children Hospital In U.S.
Brief: Nexstim's NBS System 6 Gains FDA Clearance
Brief: Nexstim Gets FDA Clearance In U.S. For OCD Treatment
Brief: Nexstim Gets Clearance For NBS 6 Diagnostics System In UAE
Brief: Nexstim Receives System Order From Distributor In India
Brief: Nexstim Gets System Order From Distributor In Middle East